Status:
UNKNOWN
The Clinical Evaluation of Efficacy of Lipid-Lowing Tea on Hyperlipidemia Patients' Lipid Profiles
Lead Sponsor:
China Medical University Hospital
Conditions:
Hyperlipidemia
Eligibility:
All Genders
20-65 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine whether the Lipid-lowing Tea is effective and safe in the treatment of Hyperlipidemia Patients
Eligibility Criteria
Inclusion
- Patient aged 20-65 years;either sex
- Patient diagnosed with hyperlipidemia(fasting levels of TC\>=200mg/dL),or TG\>=200mg/dL but \<400mg/dL,or LDL-C\>=130mg/dL)
- Patient who has signed the informed consent form
Exclusion
- Patient with pregnancy (or child bearing potential),or in lactation
- Patient with any lipid regulating agents within 4 weeks prior to study period
- Patient currently taking concomitant medications, such as oral contraceptives, or any medical treatment capable of interfering with lipid metabolism(eg thiazides, β-blockers, cyclosporins, itraconazole erythromycin,and danazol)
- Patient with medical history of hypothyroidism, pancreatitis, cholestasis, nephrotic syndrome, gall bladder disease, primary biliary cirrhosis.
- Patient with liver dysfunction (SGOT or SGPT\>2x ULN)
- Patient with renal insufficiency (serum creatinine\>1.3mg/dL)
- Patient with myocardial infarction,cerebrovascular disease,or major operations within 6 months prior to the study period.
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00316641
Last Update
November 7 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
China Medical University Hospital
Taichung, Taiwan, 404